Corcept Therapeutics
CORT
#2078
Rank
A$13.65 B
Marketcap
A$129.63
Share price
1.71%
Change (1 day)
40.71%
Change (1 year)

Corcept Therapeutics (CORT) - Net assets

Net assets on the balance sheet as of September 2025 : A$0.95 Billion

According to Corcept Therapeutics 's latest financial reports the company has A$0.95 Billion in net assets.
A companyโ€™s net assets is the sum of its assets minus the sum of its liabilities.

Corcept Therapeutics - Net assets on balance sheet (from 2003 to 2025)

Net assets by year

Year Net assets Change
2024-12-31$A$1.09 B46.91%
2023-12-31$A$0.74 B0.85%
2022-12-31$A$0.73 B42.27%
2021-12-31$A$0.51 B-23.84%
2020-12-31$A$0.68 B28.38%
2019-12-31$A$0.53 B35.38%
2018-12-31$A$0.39 B60.1%
2017-12-31$A$0.24 B326.11%
2016-12-31$A$57.4 M126.07%
2015-12-31$A$25.39 M-713.37%
2014-12-31$-A$4.14 Million-117.57%
2013-12-31$A$23.56 M-60.36%
2012-12-31$A$59.44 M75.12%
2011-12-31$A$33.94 M62.31%
2010-12-31$A$20.91 M-14.96%
2009-12-31$A$24.59 M2.62%
2008-12-31$A$23.96 M42.2%
2007-12-31$A$16.85 M108.88%
2006-12-31$A$8.06 M-77.8%
2005-12-31$A$36.34 M-38.79%
2004-12-31$A$59.37 M-240.23%
2003-12-31$-A$42.35 Million8.73%
2002-12-31$-A$38.95 Million-188.82%
2001-12-31$A$43.84 M

Net assets for similar companies or competitors

Company Net assets differencediff. Country
Johnson & Johnson
JNJ
A$119.35 B 12,445.77%๐Ÿ‡บ๐Ÿ‡ธ USA
Bristol-Myers Squibb
BMY
A$28.00 B 2,843.49%๐Ÿ‡บ๐Ÿ‡ธ USA
Novartis
NVS
A$67.37 B 6,982.11%๐Ÿ‡จ๐Ÿ‡ญ Switzerland
Eli Lilly
LLY
A$35.90 B 3,674.45%๐Ÿ‡บ๐Ÿ‡ธ USA
Pfizer
PFE
A$140.15 B 14,632.66%๐Ÿ‡บ๐Ÿ‡ธ USA
Merck
MRK
A$78.14 B 8,114.41%๐Ÿ‡บ๐Ÿ‡ธ USA
Esperion Therapeutics
ESPR
-A$0.68 Billion-171.43%๐Ÿ‡บ๐Ÿ‡ธ USA
MannKind Corp
MNKD
-A$67.08 Million-107.05%๐Ÿ‡บ๐Ÿ‡ธ USA
BioMarin Pharmaceutical
BMRN
A$9.11 B 858.49%๐Ÿ‡บ๐Ÿ‡ธ USA